DGRO vs IBB
iShares Core Dividend Growth ETF vs iShares Biotechnology ETF
- • DGRO has the lower expense ratio at 0.08% vs 0.44% for IBB.
- • DGRO pays a higher dividend yield (1.84%).
Side-by-side metrics
| Metric | DGRO | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.08% | 0.44% |
Dividend yield Trailing 12-month yield. | 1.84% | 0.16% |
AUM Assets under management — bigger funds are typically more liquid. | $45.26B | $11.50B |
YTD return | 18.79% | 30.22% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.61 | 0.60 |
P/E ratio | 21.59 | 25.48 |
Last price | $81.80 | $217.75 |
Inception | — | — |
Issuer | iShares | iShares |
DGRO top holdings
| XOM | ExxonMobil Holdings Corp | 3.33% |
| ABBV | AbbVie Inc | 3.05% |
| MSFT | Microsoft Corp | 3.04% |
| AAPL | Apple Inc | 3.04% |
| JNJ | Johnson & Johnson | 2.78% |
| JPM | JPMorgan Chase & Co | 2.66% |
| PG | Procter & Gamble Co | 2.42% |
| AVGO | Broadcom Inc | 2.40% |
| PM | Philip Morris International Inc | 2.27% |
| HD | The Home Depot Inc | 2.07% |
IBB top holdings
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
About DGRO
DGRO (iShares Core Dividend Growth ETF) is US stocks with sustained dividend growth. Managed by iShares, the fund carries $45.3B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.84%. Its largest holding is ExxonMobil Holdings Corp (XOM), which represents 3.3% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 6.1%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.